ARCHIVES

Unwanted Distinction: MSKCC Bars Zaltrap From Formulary, Triggering Debate Over Drug Pricing

This article is from The Cancer Letter archive.

Vol. 38 No. 41 | November 1, 2012

Download PDF Visit The Full Archive

Related Articles

Senate, House Budget Plans Likely To Result In Modest Funding Increases For NIH, NCI

May 11, 1990

Cure For Lymphoma Foundation Awards Five; Lefall Honored; AACR Begins New Journal.

November 23, 2001

Cvitkovic Responds To Story On March ODAC Meeting.

June 23, 2000

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982

Cyramza Combination Approved In Advanced Gastric Cancer

November 28, 2014

MEPACT Approved In Europe For Resectable Osteosarcoma

March 27, 2009